[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503974":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":35,"responsibleParty":52,"collaborators":20,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":20,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":20,"enrollmentInfo":65,"targetDuration":20,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":20,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Assaf-Harofeh Medical Center","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Hyperbaric Oxygen Therapy active arm","EXPERIMENTAL","The protocol comprises of 60 consecutive hyperbaric oxygen treatment (HBOT) sessions, 5 sessions per week within a three months' period.",[13],"Device: Hyperbaric oxygen therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Hyperbaric oxygen therapy","Each session will include exposure of 90 minutes to 100% at 2 ATA, with 5 minutes air breaks every 20 minutes",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Shachar Finci, MD","Asaf-Harofhe MC","PRINCIPAL_INVESTIGATOR",[27,31],{"name":23,"role":28,"phone":29,"phoneExt":20,"email":30},"CONTACT","97289542395","shacharf@shamir.gov.il",{"name":32,"role":28,"phone":33,"phoneExt":20,"email":34},"Shai a Efrati, MD","972549212866","efratishai@outlook.com",[36],{"facility":37,"status":38,"city":39,"state":20,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)","RECRUITING","Ẕerifin","70300","Israel","IL",{"type":44,"coordinates":45},"Point",[46,47],34.84852,31.95731,{"lat":47,"lon":46},[50],{"name":23,"role":28,"phone":51,"phoneExt":20,"email":30},"972-8-9779393",{"type":25,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Shay Efrati","MD","100503974","hyperbaric-oxygen-therapy-for-men-suffering-from-infertility-due-to-oligospermia-100503974",false,"NCT05842239","Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia.","Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia: a Pilot Study","Inclusion Criteria:\n\n1. Age above 21 years\n2. At least two sperm examination showing oligospermia (\\\u003C15·106 sperm\u002FmL)\n3. Diagnosis of idiopathic oligospermia.\n4. Subject willing and able to read, understand and sign an informed consent\n\nExclusion Criteria:\n\n1. Inability to attend scheduled clinic visits and\u002For comply with the study protocol\n2. Active malignancy\n3. Previous treatment with chemotherapy and\u002For radiation therapy\n4. Substance use at baseline\n5. Severe or unstable physical disorders or major cognitive deficits at baseline\n6. HBOT for any reason prior to study enrolment\n7. Chest pathology incompatible with pressure changes (including moderate to severe asthma)\n8. Ear or Sinus pathology incompatible with pressure changes\n9. Chronic disease like diabetes mellitus, ischemic heart disease etc.\n10. Active smoking",true,"MALE","21 Years",{"count":66,"type":67},15,"ESTIMATED","INTERVENTIONAL",[70],"NA","Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.",[73],"Oligospermia","2026-04-19",{"date":76,"type":77},"2026-04-22","ACTUAL",{"date":79,"type":77},"2024-01-20",{"date":81,"type":67},"2030-12-01",{"name":5,"class":6},1]